Index Entries

Hongtao Lv, Shubiao Zhang, Bing Wang, Shaohui Cui, and Jie Yan
August 10, 2006
Journal of Controlled Release
Dalian Nationalities University, China

Abstract: Gene therapy, as a promising therapeutics to treat genetic or acquired diseases, has achieved exciting development in the past two decades. Appropriate gene vectors can be crucial for gene transfer. Cationic lipids and polymers, the most important non-viral vectors, have many advantages over viral ones as non-immunogenic, easy to produce and not oncogenic. They hold the promise to replace viral vectors to be used in clinic. However, the toxicity is still an obstacle to the application of non-viral vectors to gene therapy.”

document
COVID-19,FDA approvals,vaccine composition,vaccine dynamics,vaccine ingredients,manufacturers,vaccine quality control,vaccines